The Efficacy of Deferring BCG Vaccination to 14 Weeks of Age in HIV-1 Exposed Infants in Uganda
Conditions: Lower Respiratory Tract Infections; Septicaemia; Diarrhoea; MalariaInterventions: Biological: Delayed BCG; Biological: Control arm: BCG at birthSponsors: Makerere University; Centre For International Health; Radboud UniversityNot yet recruiting - verified November 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials